aluates Reports

$ 0.0

Automative

Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-4H14957

Global Adeno Associated Virus AAV Gene Therapy Market Research Report 2023

BUY CHAPTERS

Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2025

Code: QYRE-Auto-4H14957

Report

May 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative-Biolabs

Spark Therapeutics

AGC Biologics

BiBo Biopharma Engineering Co., LTD.

PackGene Biotech

Sarepta Therapeutics

Roche

Affinia Therapeutics

StrideBio

SIRION Biotech

Neurophth Biotechnology

Belief BioMed

Beihai Kangcheng

Carbon BioSciences

Kelonia Therapeutics

Remedium Bio

Adeno-Associated Virus (AAV) Gene Therapy Market Size

The global market for Adeno-Associated Virus (AAV) Gene Therapy was valued at US$ 1924 million in the year 2024 and is projected to reach a revised size of US$ 3445 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Adeno-Associated Virus (AAV) Gene Therapy Market

North American market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Adeno-Associated Virus (AAV) Gene Therapy in Central Nervous System Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Adeno-Associated Virus (AAV) Gene Therapy include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed, BiBo Biopharma Engineering Co., LTD., Beihai Kangcheng, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus (AAV) Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus (AAV) Gene Therapy.

The Adeno-Associated Virus (AAV) Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adeno-Associated Virus (AAV) Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adeno-Associated Virus (AAV) Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adeno-Associated Virus (AAV) Gene Therapy Market Report

Report Metric	Details
Report Name	Adeno-Associated Virus (AAV) Gene Therapy Market
Accounted market size in year	US$ 1924 million
Forecasted market size in 2031	US$ 3445 million
CAGR	8.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Luxturna Zolgensma Others
Segment by Application	Central Nervous System Diseases Ocular Diseases Liver-directed Diseases Other Hereditary Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed, BiBo Biopharma Engineering Co., LTD., Beihai Kangcheng, PackGene Biotech, Sarepta Therapeutics, Carbon BioSciences, Kelonia Therapeutics, Roche, Remedium Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adeno-Associated Virus (AAV) Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Adeno-Associated Virus (AAV) Gene Therapy Market growing?

Ans: The Adeno-Associated Virus (AAV) Gene Therapy Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Adeno-Associated Virus (AAV) Gene Therapy Market size in 2031?

Ans: The Adeno-Associated Virus (AAV) Gene Therapy Market size in 2031 will be US$ 3445 million.

Who are the main players in the Adeno-Associated Virus (AAV) Gene Therapy Market report?

Ans: The main players in the Adeno-Associated Virus (AAV) Gene Therapy Market are Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed, BiBo Biopharma Engineering Co., LTD., Beihai Kangcheng, PackGene Biotech, Sarepta Therapeutics, Carbon BioSciences, Kelonia Therapeutics, Roche, Remedium Bio

What are the Application segmentation covered in the Adeno-Associated Virus (AAV) Gene Therapy Market report?

Ans: The Applications covered in the Adeno-Associated Virus (AAV) Gene Therapy Market report are Central Nervous System Diseases, Ocular Diseases, Liver-directed Diseases, Other Hereditary Diseases

What are the Type segmentation covered in the Adeno-Associated Virus (AAV) Gene Therapy Market report?

Ans: The Types covered in the Adeno-Associated Virus (AAV) Gene Therapy Market report are Luxturna, Zolgensma, Others

Recommended Reports

AAV Gene Therapy

Gene Therapy Technologies

Gene Therapy Applications

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Luxturna

1.2.3 Zolgensma

1.2.4 Others

1.3 Market by Application

1.3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Central Nervous System Diseases

1.3.3 Ocular Diseases

1.3.4 Liver-directed Diseases

1.3.5 Other Hereditary Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Perspective (2020-2031)

2.2 Global Adeno-Associated Virus (AAV) Gene Therapy Growth Trends by Region

2.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Adeno-Associated Virus (AAV) Gene Therapy Historic Market Size by Region (2020-2025)

2.2.3 Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Region (2026-2031)

2.3 Adeno-Associated Virus (AAV) Gene Therapy Market Dynamics

2.3.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Trends

2.3.2 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers

2.3.3 Adeno-Associated Virus (AAV) Gene Therapy Market Challenges

2.3.4 Adeno-Associated Virus (AAV) Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adeno-Associated Virus (AAV) Gene Therapy Players by Revenue

3.1.1 Global Top Adeno-Associated Virus (AAV) Gene Therapy Players by Revenue (2020-2025)

3.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Adeno-Associated Virus (AAV) Gene Therapy Revenue

3.4 Global Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Ratio

3.4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus (AAV) Gene Therapy Revenue in 2024

3.5 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy Head office and Area Served

3.6 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Product and Application

3.7 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Adeno-Associated Virus (AAV) Gene Therapy Breakdown Data by Type

4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Historic Market Size by Type (2020-2025)

4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Type (2026-2031)

5 Adeno-Associated Virus (AAV) Gene Therapy Breakdown Data by Application

5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Historic Market Size by Application (2020-2025)

5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size (2020-2031)

6.2 North America Adeno-Associated Virus (AAV) Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025)

6.4 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size (2020-2031)

7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025)

7.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size (2020-2031)

8.2 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size (2020-2031)

9.2 Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025)

9.4 Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size (2020-2031)

10.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Creative Biolabs

11.1.1 Creative Biolabs Company Details

11.1.2 Creative Biolabs Business Overview

11.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.1.4 Creative Biolabs Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.1.5 Creative Biolabs Recent Development

11.2 Affinia Therapeutics

11.2.1 Affinia Therapeutics Company Details

11.2.2 Affinia Therapeutics Business Overview

11.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.2.5 Affinia Therapeutics Recent Development

11.3 Spark Therapeutics

11.3.1 Spark Therapeutics Company Details

11.3.2 Spark Therapeutics Business Overview

11.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.3.5 Spark Therapeutics Recent Development

11.4 AGC Biologics

11.4.1 AGC Biologics Company Details

11.4.2 AGC Biologics Business Overview

11.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.4.4 AGC Biologics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.4.5 AGC Biologics Recent Development

11.5 StrideBio

11.5.1 StrideBio Company Details

11.5.2 StrideBio Business Overview

11.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.5.4 StrideBio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.5.5 StrideBio Recent Development

11.6 SIRION Biotech

11.6.1 SIRION Biotech Company Details

11.6.2 SIRION Biotech Business Overview

11.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.6.4 SIRION Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.6.5 SIRION Biotech Recent Development

11.7 Neurophth Biotechnology

11.7.1 Neurophth Biotechnology Company Details

11.7.2 Neurophth Biotechnology Business Overview

11.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.7.5 Neurophth Biotechnology Recent Development

11.8 Belief BioMed

11.8.1 Belief BioMed Company Details

11.8.2 Belief BioMed Business Overview

11.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.8.4 Belief BioMed Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.8.5 Belief BioMed Recent Development

11.9 BiBo Biopharma Engineering Co., LTD.

11.9.1 BiBo Biopharma Engineering Co., LTD. Company Details

11.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview

11.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.9.4 BiBo Biopharma Engineering Co., LTD. Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.9.5 BiBo Biopharma Engineering Co., LTD. Recent Development

11.10 Beihai Kangcheng

11.10.1 Beihai Kangcheng Company Details

11.10.2 Beihai Kangcheng Business Overview

11.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.10.5 Beihai Kangcheng Recent Development

11.11 PackGene Biotech

11.11.1 PackGene Biotech Company Details

11.11.2 PackGene Biotech Business Overview

11.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.11.4 PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.11.5 PackGene Biotech Recent Development

11.12 Sarepta Therapeutics

11.12.1 Sarepta Therapeutics Company Details

11.12.2 Sarepta Therapeutics Business Overview

11.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.12.5 Sarepta Therapeutics Recent Development

11.13 Carbon BioSciences

11.13.1 Carbon BioSciences Company Details

11.13.2 Carbon BioSciences Business Overview

11.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.13.5 Carbon BioSciences Recent Development

11.14 Kelonia Therapeutics

11.14.1 Kelonia Therapeutics Company Details

11.14.2 Kelonia Therapeutics Business Overview

11.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.14.5 Kelonia Therapeutics Recent Development

11.15 Roche

11.15.1 Roche Company Details

11.15.2 Roche Business Overview

11.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.15.4 Roche Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.15.5 Roche Recent Development

11.16 Remedium Bio

11.16.1 Remedium Bio Company Details

11.16.2 Remedium Bio Business Overview

11.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Introduction

11.16.4 Remedium Bio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

11.16.5 Remedium Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative-Biolabs

Spark Therapeutics

AGC Biologics

BiBo Biopharma Engineering Co., LTD.

PackGene Biotech

Sarepta Therapeutics

Roche

Affinia Therapeutics

StrideBio

SIRION Biotech

Neurophth Biotechnology

Belief BioMed

Beihai Kangcheng

Carbon BioSciences

Kelonia Therapeutics

Remedium Bio

List of Tables

Table 1. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Luxturna

Table 3. Key Players of Zolgensma

Table 4. Key Players of Others

Table 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Region (2020-2025)

Table 9. Global Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Region (2026-2031)

Table 11. Adeno-Associated Virus (AAV) Gene Therapy Market Trends

Table 12. Adeno-Associated Virus (AAV) Gene Therapy Market Drivers

Table 13. Adeno-Associated Virus (AAV) Gene Therapy Market Challenges

Table 14. Adeno-Associated Virus (AAV) Gene Therapy Market Restraints

Table 15. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Players (2020-2025)

Table 17. Global Top Adeno-Associated Virus (AAV) Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Gene Therapy as of 2024)

Table 18. Ranking of Global Top Adeno-Associated Virus (AAV) Gene Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Adeno-Associated Virus (AAV) Gene Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Headquarters and Area Served

Table 21. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Product and Application

Table 22. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global Adeno-Associated Virus (AAV) Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Creative Biolabs Company Details

Table 48. Creative Biolabs Business Overview

Table 49. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product

Table 50. Creative Biolabs Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 51. Creative Biolabs Recent Development

Table 52. Affinia Therapeutics Company Details

Table 53. Affinia Therapeutics Business Overview

Table 54. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product

Table 55. Affinia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 56. Affinia Therapeutics Recent Development

Table 57. Spark Therapeutics Company Details

Table 58. Spark Therapeutics Business Overview

Table 59. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product

Table 60. Spark Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 61. Spark Therapeutics Recent Development

Table 62. AGC Biologics Company Details

Table 63. AGC Biologics Business Overview

Table 64. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product

Table 65. AGC Biologics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 66. AGC Biologics Recent Development

Table 67. StrideBio Company Details

Table 68. StrideBio Business Overview

Table 69. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product

Table 70. StrideBio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 71. StrideBio Recent Development

Table 72. SIRION Biotech Company Details

Table 73. SIRION Biotech Business Overview

Table 74. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product

Table 75. SIRION Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 76. SIRION Biotech Recent Development

Table 77. Neurophth Biotechnology Company Details

Table 78. Neurophth Biotechnology Business Overview

Table 79. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product

Table 80. Neurophth Biotechnology Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 81. Neurophth Biotechnology Recent Development

Table 82. Belief BioMed Company Details

Table 83. Belief BioMed Business Overview

Table 84. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product

Table 85. Belief BioMed Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 86. Belief BioMed Recent Development

Table 87. BiBo Biopharma Engineering Co., LTD. Company Details

Table 88. BiBo Biopharma Engineering Co., LTD. Business Overview

Table 89. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product

Table 90. BiBo Biopharma Engineering Co., LTD. Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 91. BiBo Biopharma Engineering Co., LTD. Recent Development

Table 92. Beihai Kangcheng Company Details

Table 93. Beihai Kangcheng Business Overview

Table 94. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product

Table 95. Beihai Kangcheng Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 96. Beihai Kangcheng Recent Development

Table 97. PackGene Biotech Company Details

Table 98. PackGene Biotech Business Overview

Table 99. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product

Table 100. PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 101. PackGene Biotech Recent Development

Table 102. Sarepta Therapeutics Company Details

Table 103. Sarepta Therapeutics Business Overview

Table 104. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product

Table 105. Sarepta Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 106. Sarepta Therapeutics Recent Development

Table 107. Carbon BioSciences Company Details

Table 108. Carbon BioSciences Business Overview

Table 109. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product

Table 110. Carbon BioSciences Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 111. Carbon BioSciences Recent Development

Table 112. Kelonia Therapeutics Company Details

Table 113. Kelonia Therapeutics Business Overview

Table 114. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product

Table 115. Kelonia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 116. Kelonia Therapeutics Recent Development

Table 117. Roche Company Details

Table 118. Roche Business Overview

Table 119. Roche Adeno-Associated Virus (AAV) Gene Therapy Product

Table 120. Roche Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 121. Roche Recent Development

Table 122. Remedium Bio Company Details

Table 123. Remedium Bio Business Overview

Table 124. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product

Table 125. Remedium Bio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025) & (US$ Million)

Table 126. Remedium Bio Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Picture

Figure 2. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type: 2024 VS 2031

Figure 4. Luxturna Features

Figure 5. Zolgensma Features

Figure 6. Others Features

Figure 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application: 2024 VS 2031

Figure 9. Central Nervous System Diseases Case Studies

Figure 10. Ocular Diseases Case Studies

Figure 11. Liver-directed Diseases Case Studies

Figure 12. Other Hereditary Diseases Case Studies

Figure 13. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered

Figure 14. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Players in 2024

Figure 18. Global Top Adeno-Associated Virus (AAV) Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Gene Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Adeno-Associated Virus (AAV) Gene Therapy Revenue in 2024

Figure 20. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Adeno-Associated Virus (AAV) Gene Therapy Market Share by Country (2020-2031)

Figure 22. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Share by Country (2020-2031)

Figure 26. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Share by Region (2020-2031)

Figure 34. China Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market Share by Country (2020-2031)

Figure 42. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Share by Country (2020-2031)

Figure 46. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Creative Biolabs Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 50. Affinia Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 51. Spark Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 52. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 53. StrideBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 54. SIRION Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 55. Neurophth Biotechnology Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 56. Belief BioMed Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 57. BiBo Biopharma Engineering Co., LTD. Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 58. Beihai Kangcheng Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 59. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 60. Sarepta Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 61. Carbon BioSciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 62. Kelonia Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 63. Roche Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 64. Remedium Bio Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AAV Vector Gene Therapy Market Research Report 2024

Global AAV Plasmid Market Research Report 2025

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Adeno Associated Virus Vectors in Gene Therapy Market Research Report 2025

Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ocular Gene Therapy Market Research Report 2024

Global In Vitro Gene Therapy Market Research Report 2025

Global AAV Gene Therapy Drugs Market Research Report 2024

Global Ophthalmic AAV Gene Therapy Market Research Report 2024

Global Cell and Gene Therapy Solutions Market Research Report 2025

Global Viral Vector Based Gene Therapy Market Research Report 2025

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2024

Gene Therapy For Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AAV based Gene Therapy Products Market Research Report 2024

Osteoarthritis Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global Gene Therapy Drug Delivery Tube Market Research Report 2024

Drug and Gene Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions